Minia C. D.
- Country
- Spain
- Department
- Servicio de Dermatología
Research Overview
- A Phase 3, Open-label, 52-week Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab (AMG 451) in Adolescent Subjects Aged ≥ 12 to < 18 years With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Orbit)
- OptIMMize-2: A Phase 3 Multicenter, Single-arm, Open-label Extension Study to Assess the Safety, Tolerability, and Efficacy of Risankizumab in Subjects With Moderate to Severe Plaque Psoriasis Who Have Completed Participation in Study M19-977 (OptIMMize-1).
- Efficacy and Safety of Alpelisib in Pediatric and Adult Patients with PIK3CA-Mutated Lymphatic Malformations: A Randomized, Double-Blind, Placebo-Controlled Study
Data & Insights
Has run more than one trial at 142 of 318 partner sites.
Specializations
Dermatological Conditions
This investigator specializes in treating severe dermatological conditions, with particular emphasis on atopic dermatitis and plaque psoriasis. Their research focuses on innovative therapeutic approaches for both adult and pediatric populations.
- Moderate to severe atopic dermatitis management
- Pediatric plaque psoriasis treatment
- Chronic skin condition therapies
Pediatric Dermatology
The investigator has developed significant expertise in treating young patients, particularly focusing on adolescent dermatological conditions. Their work encompasses treatment strategies for patients aged 6 to 18 years.
- Adolescent-specific therapeutic approaches
- Age-appropriate treatment protocols
- Long-term disease management in young patients
Therapeutic Innovation
The investigator explores novel treatment modalities including monotherapy approaches and biological treatments for dermatological conditions. Their work includes evaluation of maintenance therapies and treatment response patterns.
- Novel biological therapeutics
- Treatment response assessment
- Long-term efficacy evaluation
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.